Askina® Sorb by B. Braun is a primary sterile conformable dressing based on calcium alginate and hydrocolloids (Carboxymethylcellulose - CMC), indicated for the treatment of moderately to profusely exuding wounds.

Askina® Sorb absorbs exudate vertically over the entire surface of the dressing. The alginate and hydrocolloid fibers react on contact with the exudate to form a soft, firm gel. This gel, in addition to absorbing the exudate, allows the maintenance of ideal moisture conditions that promote the healing process. The gel also allows gaseous exchange with the wound surface, protecting the bottom of the wound from the rubbing of a secondary covering dressing.

Indications for use.
Askina® Sorb is a highly absorbent dressing indicated for the treatment of moderately to severely exuding, partial- or full-thickness wounds, infection and/or bleeding, in the presence of fibrin or necrosis It should not be used with surgical implants or third-degree burns.

Askina® Sorb can be used in the treatment of injuries such as:
- Pressure sores
- Arterial ulcers
- Venous ulcers
- Diabetic ulcers
- Skin transplants
- Acute wounds
- Injuries of the dermis

When the dressing is changed, removal is done completely and atraumatically, with a simple washing with saline or other cleansing solution, without any damage to the newly formed tissue or any residual dressing remaining within the wound. Technical information
- Hydroactive surface 36 cm2
- Thickness: 2.5 mm (± 0.1 mm)
- Weight: 1.39 g/100 cm2
- Absorption after 30 minutes:
- 1 gram of dressing absorbs 20 grams of solution
- 20.20 g/g
- 28.08 g/100cm2
- 0.28 g/cm2
- 2808 g/m2
- Absorption after 24 hours:
- 18.80 g/g
- 26.14 g/100 cm2
- 0.2614 g/cm2
- 2614 g/m2
- Residence time: 7 days

Composition
- 85% Nonwoven calcium alginate fibers derived from Alginic acid extracted from brown algae with high Guluronic acid content (65 - 75%) and reduced Mannuronic acid content (25 - 35%)
- 15% Carboxymethylcellulose (CMC)

Askina® Sorb by B. Braun is a primary sterile conformable dressing based on calcium alginate and hydrocolloids (Carboxymethylcellulose - CMC), indicated for the treatment of moderately to profusely exuding wounds.

Askina® Sorb absorbs exudate vertically over the entire surface of the dressing. The alginate and hydrocolloid fibers react on contact with the exudate to form a soft, firm gel. This gel, in addition to absorbing the exudate, allows the maintenance of ideal moisture conditions that promote the healing process. The gel also allows gaseous exchange with the wound surface, protecting the bottom of the wound from the rubbing of a secondary covering dressing.

Indications for use.
Askina® Sorb is a highly absorbent dressing indicated for the treatment of moderately to severely exuding, partial- or full-thickness wounds, infection and/or bleeding, in the presence of fibrin or necrosis It should not be used with surgical implants or third-degree burns.

Askina® Sorb can be used in the treatment of injuries such as:
- Pressure sores
- Arterial ulcers
- Venous ulcers
- Diabetic ulcers
- Skin transplants
- Acute wounds
- Injuries of the dermis

When the dressing is changed, removal is done completely and atraumatically, with a simple washing with saline or other cleansing solution, without any damage to the newly formed tissue or any residual dressing remaining within the wound. Technical information
- Hydroactive surface 36 cm2
- Thickness: 2.5 mm (± 0.1 mm)
- Weight: 1.39 g/100 cm2
- Absorption after 30 minutes:
- 1 gram of dressing absorbs 20 grams of solution
- 20.20 g/g
- 28.08 g/100cm2
- 0.28 g/cm2
- 2808 g/m2
- Absorption after 24 hours:
- 18.80 g/g
- 26.14 g/100 cm2
- 0.2614 g/cm2
- 2614 g/m2
- Residence time: 7 days

Composition
- 85% Nonwoven calcium alginate fibers derived from Alginic acid extracted from brown algae with high Guluronic acid content (65 - 75%) and reduced Mannuronic acid content (25 - 35%)
- 15% Carboxymethylcellulose (CMC)

Askina® Sorb by B. Braun is a primary sterile conformable dressing based on calcium alginate and hydrocolloids (Carboxymethylcellulose - CMC), indicated for the treatment of moderately to profusely exuding wounds.

Askina® Sorb absorbs exudate vertically over the entire surface of the dressing. The alginate and hydrocolloid fibers react on contact with the exudate to form a soft, firm gel. This gel, in addition to absorbing the exudate, allows the maintenance of ideal moisture conditions that promote the healing process. The gel also allows gaseous exchange with the wound surface, protecting the bottom of the wound from the rubbing of a secondary covering dressing.

Indications for use.
Askina® Sorb is a highly absorbent dressing indicated for the treatment of moderately to severely exuding, partial- or full-thickness wounds, infection and/or bleeding, in the presence of fibrin or necrosis It should not be used with surgical implants or third-degree burns.

Askina® Sorb can be used in the treatment of injuries such as:
- Pressure sores
- Arterial ulcers
- Venous ulcers
- Diabetic ulcers
- Skin transplants
- Acute wounds
- Injuries of the dermis

When the dressing is changed, removal is done completely and atraumatically, with a simple washing with saline or other cleansing solution, without any damage to the newly formed tissue or any residual dressing remaining within the wound. Technical information
- Hydroactive surface 36 cm2
- Thickness: 2.5 mm (± 0.1 mm)
- Weight: 1.39 g/100 cm2
- Absorption after 30 minutes:
- 1 gram of dressing absorbs 20 grams of solution
- 20.20 g/g
- 28.08 g/100cm2
- 0.28 g/cm2
- 2808 g/m2
- Absorption after 24 hours:
- 18.80 g/g
- 26.14 g/100 cm2
- 0.2614 g/cm2
- 2614 g/m2
- Residence time: 7 days

Composition
- 85% Nonwoven calcium alginate fibers derived from Alginic acid extracted from brown algae with high Guluronic acid content (65 - 75%) and reduced Mannuronic acid content (25 - 35%)
- 15% Carboxymethylcellulose (CMC)

Askina® Sorb by B. Braun is a primary sterile conformable dressing based on calcium alginate and hydrocolloids (Carboxymethylcellulose - CMC), indicated for the treatment of moderately to profusely exuding wounds.

Askina® Sorb absorbs exudate vertically over the entire surface of the dressing. The alginate and hydrocolloid fibers react on contact with the exudate to form a soft, firm gel. This gel, in addition to absorbing the exudate, allows the maintenance of ideal moisture conditions that promote the healing process. The gel also allows gaseous exchange with the wound surface, protecting the bottom of the wound from the rubbing of a secondary covering dressing.

Indications for use.
Askina® Sorb is a highly absorbent dressing indicated for the treatment of moderately to severely exuding, partial- or full-thickness wounds, infection and/or bleeding, in the presence of fibrin or necrosis It should not be used with surgical implants or third-degree burns.

Askina® Sorb can be used in the treatment of injuries such as:
- Pressure sores
- Arterial ulcers
- Venous ulcers
- Diabetic ulcers
- Skin transplants
- Acute wounds
- Injuries of the dermis

When the dressing is changed, removal is done completely and atraumatically, with a simple washing with saline or other cleansing solution, without any damage to the newly formed tissue or any residual dressing remaining within the wound. Technical information
- Hydroactive surface 36 cm2
- Thickness: 2.5 mm (± 0.1 mm)
- Weight: 1.39 g/100 cm2
- Absorption after 30 minutes:
- 1 gram of dressing absorbs 20 grams of solution
- 20.20 g/g
- 28.08 g/100cm2
- 0.28 g/cm2
- 2808 g/m2
- Absorption after 24 hours:
- 18.80 g/g
- 26.14 g/100 cm2
- 0.2614 g/cm2
- 2614 g/m2
- Residence time: 7 days

Composition
- 85% Nonwoven calcium alginate fibers derived from Alginic acid extracted from brown algae with high Guluronic acid content (65 - 75%) and reduced Mannuronic acid content (25 - 35%)
- 15% Carboxymethylcellulose (CMC)

Askina® SilNet is a sterile, water-repellent, thin, porous, low-adherent contact dressing made of a conformable nonwoven material and coated on both sides with a soft silicone layer.

In contact with the wound, Askina® SilNet allows exudate to pass to an absorbent secondary dressing, thus preventing maceration of the perilesional edges. The low adhesion of the soft silicone layer minimizes the risk of trauma during dressing changes.
Askina® SilNet does not absorb wound exudate.

Indications for use.
Askina® SilNet is indicated for the treatment of a wide range of full- or partial-thickness injuries such as second-degree burns, skin grafts, harvest sites, postoperative injuries, fragile skin tears, other types of tears, stage I to IV pressure ulcers, venous, arterial and neuropathic ulcers.
Askina® SilNet is compatible with negative topical pressure therapy and application of topical ointments.
It can be left in situ for up to 14 days.

Do not use Askina® SilNet for ulcers resulting from infections such as tuberculosis, syphilis or deep mycotic infections, and for third-degree burns. Do not use excessive pressure on Askina® SilNet when using it on mesh grafts. Replace after 5 days after fixation of the skin graft.

The use of Askina® SilNet:
- Minimizes trauma during dressing changes
- Determines cost-effectiveness as it can remain in situ for up to 14 days
- Minimizes the risks of maceration of perilesional skin
- Leaves no residue and remains intact over time
- Allows inspection of the lesion
- Conforms effectively to various body areas
- Does not generate irritation and allergies - Hydroactive surface area 37.5 cm2
- Thickness: 0.39 mm (390 µm)
- Weight: 550 g/m2
-Permeability (MVTR) opo 24 hours at 40C° :
- 5000 g/m2
- 0.5 g/cm2
- Tensile strength: > 1000 gf
- Adhesiveness to a steel surface: 9-> 17 gf/25 mm
- Air porosity: < 3 seconds
- Residence time: up to 14 days

Askina® SilNet is a sterile, water-repellent, thin, porous, low-adherent contact dressing made of a conformable nonwoven material and coated on both sides with a soft silicone layer.

In contact with the wound, Askina® SilNet allows exudate to pass to an absorbent secondary dressing, thus preventing maceration of the perilesional edges. The low adhesion of the soft silicone layer minimizes the risk of trauma during dressing changes.
Askina® SilNet does not absorb wound exudate.

Indications for use.
Askina® SilNet is indicated for the treatment of a wide range of full- or partial-thickness injuries such as second-degree burns, skin grafts, harvest sites, postoperative injuries, fragile skin tears, other types of tears, stage I to IV pressure ulcers, venous, arterial and neuropathic ulcers.
Askina® SilNet is compatible with negative topical pressure therapy and application of topical ointments.
It can be left in situ for up to 14 days.

Do not use Askina® SilNet for ulcers resulting from infections such as tuberculosis, syphilis or deep mycotic infections, and for third-degree burns. Do not use excessive pressure on Askina® SilNet when using it on mesh grafts. Replace after 5 days after fixation of the skin graft.

The use of Askina® SilNet:
- Minimizes trauma during dressing changes
- Determines cost-effectiveness as it can remain in situ for up to 14 days
- Minimizes the risks of maceration of perilesional skin
- Leaves no residue and remains intact over time
- Allows inspection of the lesion
- Conforms effectively to various body areas
- Does not generate irritation and allergies - Hydroactive surface area 37.5 cm2
- Thickness: 0.39 mm (390 µm)
- Weight: 550 g/m2
-Permeability (MVTR) opo 24 hours at 40C° :
- 5000 g/m2
- 0.5 g/cm2
- Tensile strength: > 1000 gf
- Adhesiveness to a steel surface: 9-> 17 gf/25 mm
- Air porosity: < 3 seconds
- Residence time: up to 14 days

Askina® SilNet is a sterile, water-repellent, thin, porous, low-adherent contact dressing made of a conformable nonwoven material and coated on both sides with a soft silicone layer.

In contact with the wound, Askina® SilNet allows exudate to pass to an absorbent secondary dressing, thus preventing maceration of the perilesional edges. The low adhesion of the soft silicone layer minimizes the risk of trauma during dressing changes.
Askina® SilNet does not absorb wound exudate.

Indications for use.
Askina® SilNet is indicated for the treatment of a wide range of full- or partial-thickness injuries such as second-degree burns, skin grafts, harvest sites, postoperative injuries, fragile skin tears, other types of tears, stage I to IV pressure ulcers, venous, arterial and neuropathic ulcers.
Askina® SilNet is compatible with negative topical pressure therapy and application of topical ointments.
It can be left in situ for up to 14 days.

Do not use Askina® SilNet for ulcers resulting from infections such as tuberculosis, syphilis or deep mycotic infections, and for third-degree burns. Do not use excessive pressure on Askina® SilNet when using it on mesh grafts. Replace after 5 days after fixation of the skin graft.

The use of Askina® SilNet:
- Minimizes trauma during dressing changes
- Determines cost-effectiveness as it can remain in situ for up to 14 days
- Minimizes the risks of maceration of perilesional skin
- Leaves no residue and remains intact over time
- Allows inspection of the lesion
- Conforms effectively to various body areas
- Does not generate irritation and allergies - Hydroactive surface area 37.5 cm2
- Thickness: 0.39 mm (390 µm)
- Weight: 550 g/m2
-Permeability (MVTR) opo 24 hours at 40C° :
- 5000 g/m2
- 0.5 g/cm2
- Tensile strength: > 1000 gf
- Adhesiveness to a steel surface: 9-> 17 gf/25 mm
- Air porosity: < 3 seconds
- Residence time: up to 14 days

Askina® Barrier Film by B. Braun is a silicone-based protective spray for peristomal and perilesional skin. Alcohol-free, it can be used on injured or damaged skin without causing burning or discomfort.

The film is transparent (to allow visual inspection of the skin) and permeable to oxygen and moisture.
One bottle guarantees more than 140 dispensing and its protection is guaranteed for up to 3 days.

Indications for use.
Askina® Barrier Film spray is indicated:
- against irritation from organic fluids
- for sensitive and delicate skin under adhesive dressings to reduce the risk of damage to newly healing tissue
- for damaged skin
- for skin lacerations
- to protect perilesional and peristomal areas
- for small cuts and lacerations
- for sites of attachment of drainage tubes and external catheters Composition
- Disiloxane: 93% w/w
- Acrylic Copolymer: 7% w/w

The SUSI® (Single Use Surgical Instrument) line, manufactured from new generation, glass-fiber reinforced plastic materials, ensures efficiency and ergonomics in various surgical procedures.

- SUSI®s are made from a specially developed plastic for optimal tactile sensation and reliability in every surgical practice
- The environmental impact of SUSI® has been shown to be less than the use of steel disposable instrumentation.
- The instruments are clearly identifiable as disposable, are biocompatible, and possess a five-year sterility guarantee

PVC extension tubes for low-pressure infusions of drugs, standard and nutritional solutions, needed to manage infusion therapy without length limitation.

Resistance to hydrostatic pressure: 4.5 bar Constituent materials
- Tube: polyvinyl chloride (PVC, DEHP-free)
- Tube fitting: acrylonitrile-butadiene-styrene (ABS)
- Luer-lock fittings: acrylonitrile-butadiene-styrene (ABS)
- Injection cap body (Ref. 4247116): acrylonitrile-butadiene-styrene (ABS)
- Injection cap membrane (Ref. 4247116) : natural rubber
- Other materials used for protective caps, fittings, plugs, regulators, etc. : PP, PS, PE, SB, ASA
-Inks and materials used for printing labels or stamping on fittings, tubes, catheters, etc., are absolutely non-toxic.